GILDER GAGNON HOWE & CO LLC 13D/13G Filings for Stoke Therapeutics, Inc. (STOK)

GILDER GAGNON HOWE & CO LLC 13D and 13G filings for Stoke Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2021-02-16
10:07 am
Sale		 2020-12-31 13G Stoke Therapeutics, Inc.
STOK		 GILDER GAGNON HOWE & CO LLC 1,470,841
4.060%		 -356,360decrease
(-19.50%)		 Filing